Term ends Jul 29, 2036 · High confidence
20-year base term ends Oct 16, 2035
Held by Sage Therapeutics, LLC
Filed Jan 21, 2020 as application 16/748,117 · Granted Dec 20, 2022
Base term plus 287 days of patent term adjustment (USPTO delay)
Today
2015
2036
Clock starts
Oct 16, 2015
Oct 16, 2015
Term ends
Jul 29, 2036
Jul 29, 2036
Granted
Dec 20, 2022
Dec 20, 2022
287
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
7
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 287 days past its 20-year base term on prosecution delay. 1 of 3 maintenance fees is paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Oct 16, 2015, when application PCT/US2015/056054, the earliest non-provisional in its chain, was filed (this one was filed Jan 21, 2020) | Oct 16, 2035 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +287 days, USPTO patent term adjustment record | Jul 29, 2036 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jul 29, 2036 | High confidence |
This family
| Application PCT/US2015/056054 | PCT application no patent term | no patent term |
| US 10,577,390 | In force Oct 2035 | Oct 2035 |
| Application 16/206,472 | Abandoned not computed | not computed |
| US 11,530,237 | this patent Jul 2036 | Jul 2036 |
| US 11,542,297 | In force Oct 2035 | Oct 2035 |
| US 12,065,463 | In force Oct 2035 | Oct 2035 |
| Application 18/741,425 | Pending not computed | not computed |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Feb 10, 2022 Reel 58972, frame 827 | Botella, Gabriel Martinez; Salituro, Francesco G.; Robichaud, Albert Jean; Harrison, Boyd L. | Sage Therapeutics, Inc. | Assignment of Assignor's Interest |
| Apr 23, 2026 Reel 75472, frame 569 | Sage Therapeutics, Inc. | Sage Therapeutics, LLC | Change of Name |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Jul 2036
Term ends Jul 29, 2036. Maintenance fees still fall due before then
Note
The 287 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
15
later US patents cite this one
That is top 10% of utility patents granted in 2022 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.